ndma

  • FDA Demands Zantac Heartburn Drug And Generics Pulled Over Carcinogen Fears

    FDA Demands Zantac Heartburn Drug And Generics Pulled Over Carcinogen Fears

    The U.S. Food and Drug Administration is taking a drastic step over a common drug used to treat allergies and acid reflux, following an investigation that confirmed the persistent presence of a likely carcinogen in products containing it. On Wednesday, the agency announced that it’s requesting all manufacturers of ranitidine to immediately pull any remaining…